1

The Blue Pill and Big Pharma: A Dangerous Investment?

News Discuss 
The legacy of Sildenafil offers a intricate case study for investors eyeing drug companies. While first sales were astounding, present patent expiration and the rise of generic versions have severely impacted earnings. https://lancefjqn575375.blogscribble.com/profile

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story